SIRPA and esophageal squamous cell carcinoma: This study systematically investigated the prognostic significance of CD47 and SIRPα expression in patients with resectable ESCC, highlighting the role of the CD47-SIRPα axis as a potential mechanism of immune evasion and a target for immunotherapy.